Tenet Healthcare Corporation
NYSE:THCMedical - Care Facilities
-$5.06 today
- Market cap
- $21.60B
- Beta
- 1.28
- P/E (TTM)
- 9.1
- EPS (TTM)
- $19.62
Volume 1.57M
Average 1.41M
THC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Tenet Healthcare CorporationNYSE: THC
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$5M, compared with $109M a year earlier. Trailing-twelve-month accounts receivables was -$53M.
Context
- Accounts receivables amounted to 0.1% of revenue in FY2025, down 1.1 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$5M or moves back toward the trailing-twelve-month quarterly average of -$13.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 20M USD
- Year-over-year change
- -91.8%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20M | -91.8% |
| FY2024 | 2024-12-31 | 245M | +944.8% |
| FY2023 | 2023-12-31 | (29M) | +79.3% |
| FY2022 | 2022-12-31 | (140M) | +28.9% |
| FY2021 | 2021-12-31 | (197M) | — |
Accounts Receivables vs competitors
How THC compares with its peers on the latest reported figures
- THC's LTM Jun 2026 accounts receivables of $53M is the 4th largest of the 7 companies compared; the peer median is $37.16M.
- Its year-over-year change of -125.5% is the lowest of 7, against a peer median of +190.0%.
- Accounts receivables amounts to 0.2% of revenue for THC, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.83B | +843.8% | -51.0% | 2.3% | |
| LTM Jun 2026 | $363.26M | +297.2% | +7.2% | 2.0% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $89.9M | +276.1% | — | 1.4% |
| LTM Jun 2026 | $53M | -125.5% | — | 0.2% | |
| LTM Sep 2026 | $45.7M | -6.0% | +15.1% | 1.4% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $28.63M | +47.8% | +23.4% | 1.2% |
| LTM Mar 2026 | $6M | +103.9% | +65.1% | 0.0% | |
| Peer median (excluding THC) | $37.16M | +190.0% | +15.1% | 1.4% | |
Competitors are the stored peer set for THC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.48B | 1B | 1.31B | 4.06B | 1.41B |
| Depreciation & Amortization | 855M | 841M | 870M | 818M | 863M |
| Deferred Income Tax | 250M | 209M | 52M | (103M) | 0 |
| Stock-Based Compensation | 56M | 56M | 66M | 67M | 104M |
| Change in Working Capital | (737M) | (1.14B) | 71M | 136M | (44M) |
| Accounts Receivables | (197M) | (140M) | (29M) | 245M | 20M |
| Inventory | (52M) | (64M) | (139M) | (86M) | (73M) |
| Accounts Payables | (584M) | (898M) | 215M | (30M) | 0 |
| Other Working Capital | 96M | (41M) | 24M | 7M | 9M |
| Other Non-Cash Items | (332M) | 119M | 4M | (2.94B) | 1.21B |
| Operating Cash Flow | 1.57B | 1.08B | 2.37B | 2.05B | 3.54B |
| Capital Expenditures | (658M) | (762M) | (751M) | (931M) | (1.01B) |
| Acquisitions (Net) | (1.22B) | (234M) | (224M) | (571M) | (308M) |
| Purchases of Investments | (108M) | (92M) | (104M) | (94M) | (90M) |
| Sales of Investments | 31M | 76M | 50M | 63M | 93M |
| Other Investing Activities | 1.24B | 204M | 60M | 4.96B | 40M |
| Investing Cash Flow | (714M) | (808M) | (969M) | 3.43B | (1.28B) |
| Debt Repayment | (349M) | (828M) | (172M) | (2.22B) | (96M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (250M) | (200M) | (672M) | (1.44B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (587M) | (703M) | (663M) | (793M) | (868M) |
| Financing Cash Flow | (936M) | (1.78B) | (1.04B) | (3.69B) | (2.4B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (82M) | (1.51B) | 370M | 1.79B | (136M) |
| Free Cash Flow | 910M | 321M | 1.62B | 1.12B | 2.53B |
Tenet Healthcare Corporation
NYSE:THC
Intrinsic Alpha fair value
Locked
Current Price
$271.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.